Stay updated with breaking news from Dose Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
02.06.2022 - KANSAS CITY, Kan., June 02, 2022 (GLOBE NEWSWIRE) - Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release (PTR) drug delivery platform technology to build and advance a pipeline ...
-Positive Efficacy Signals from Trials of Prevention and Treatment of COVID-19--Improvement of Respiratory Symptoms and Fewer Intensive Care Admissions from Previously Reported Trial in Patients with COVID-19--Potential Activity Against All SARS-CoV-2 Variants-HOUSTON--(BUSINESS WIRE)--#biotech--Pulmotect, Inc., a c...
Systems haven't mounted the same immune response against the virus. >> vin, these boosters are only for those that got pfizer or moderna. what about people that got johnson & johnson vaccine? >> that's an important point. i am a firm believer we should allow those individuals to get a second shot now, not waiting a few months to finish the clinical trial. johnson & johnson is coming out with a two dose study in the next month, hopefully will have clarity for the 13 million that first got the shot. you bring up an important point. let me zoom out and say it is important we focus on data that we...